Literature DB >> 8625607

Giant cell tumor of bone.

K M Yip1, P C Leung, S M Kumta.   

Abstract

Giant cell tumor is a locally aggressive tumor with a high recurrence rate if not completely excised. The condition is more common among Asians than whites. During a 10-year period 44 patients, ranging in age from 12 to 51 years, were treated. The most common sites were the proximal femur and the distal radius. The aim of treatment was to excise the tumor completely. Because the tumor usually occurred at the juxtaarticular region of the bone, difficult reconstruction was expected. The authors' method of choice for filling large defects resulting from resection was to use a large vascularized bone graft from the iliac crest to enhance bone to bone corporation. The recurrence rate was low (4.5%), with only 2 recurrences: 1 at the proximal femur and the other at the proximal tibia. The functional results were highly satisfactory, with excellent stability of the joint, although in the case of the distal radius there was some degree of subluxation of the wrist joint. By applying microsurgical technique for the reconstruction, one was able to be more aggressive with excision of this locally aggressive tumor while maintaining excellent functional results. In the case of the knee, as long as 1 tibial condyle was intact, reconstruction of the other condyle using a vascularized iliac crest block maintained the joint integrity perfectly or created a pseudojoint component that was perfectly stable.

Entities:  

Mesh:

Year:  1996        PMID: 8625607     DOI: 10.1097/00003086-199602000-00008

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  14 in total

1.  Orthopaedic . Radiology . Pathology Conference: Painful distal femur Lesion in a 13-year-old girl.

Authors:  Asheesh Harsha; Camilo E Villalobos; Leon D Rybak; Dariusz Borys; James C Wittig
Journal:  Clin Orthop Relat Res       Date:  2008-09-18       Impact factor: 4.176

2.  Giant cell tumour of the neck of femur treated by total hip replacement.

Authors:  N C Mkandawire
Journal:  Malawi Med J       Date:  2005-06       Impact factor: 0.875

Review 3.  Giant-cell tumours of bone of the hand and wrist: a review of imaging findings and differential diagnoses.

Authors:  S L J James; A M Davies
Journal:  Eur Radiol       Date:  2005-05-03       Impact factor: 5.315

4.  Disappearance of giant cells and presence of newly formed bone in the pulmonary metastasis of a sacral giant-cell tumor following denosumab treatment: A case report.

Authors:  Tetsuro Yamagishi; Hiroyuki Kawashima; Akira Ogose; Taro Sasaki; Tetsuo Hotta; Shoichi Inagawa; Hajime Umezu; Naoto Endo
Journal:  Oncol Lett       Date:  2015-11-04       Impact factor: 2.967

5.  Retrospective analysis of patients with rare-site and metastatic giant cell tumor.

Authors:  Junling Liu; Han Yang; Rui Sun; Zhijun Yang; Zhihua Zhu
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

6.  Giant cell tumor of bone: Is curettage the answer?

Authors:  Shishir Rastogi; I Prashanth; Shah Alam Khan; Vivek Trikha; Ravi Mittal
Journal:  Indian J Orthop       Date:  2007-04       Impact factor: 1.251

7.  Giant cell tumour--a very rare differential for a lytic lesion of the medial condyle of the humerous.

Authors:  Jatin Prakash; Anil Mehtani; Tankeshwar Baruah
Journal:  BMJ Case Rep       Date:  2015-06-25

8.  Resection arthrodesis for giant cell tumors around the knee.

Authors:  Sudhir K Kapoor; Akshay Tiwari
Journal:  Indian J Orthop       Date:  2007-04       Impact factor: 1.251

9.  Iterative curettage is associated with local control in giant cell tumors involving the distal tibia.

Authors:  Saleh A AlSulaimani; Robert E Turcotte
Journal:  Clin Orthop Relat Res       Date:  2013-04-09       Impact factor: 4.176

10.  Recurrent giant cell tumor of foot detected by F18-FDG PET/CT.

Authors:  Kuruva Manohar; Bhagwant Rai Mittal; Anish Bhattacharya; Ramesh Sen
Journal:  Indian J Nucl Med       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.